In moderate anaemia cases, before and after four weeks of therapy, Hb levels increased from 7.21 to 10.04 gm/dl in the IV group (p<0.05) while in the oral iron group, it increased from 7.54 to 8.33 (p>0.05). This evidence concerns the gene GSTM1 and anemia.